$AHR · American Healthcare REIT, Inc.
American Healthcare REIT filed its Q3 FY2026 10-Q. Revenue grew 29.5% YoY to $742.1M, driven by resident fees and services ($701.1M vs $532.1M). Net income attributable to controlling interest fell to $31.2M ($0.14/share) from $55.9M ($0.33/share), as depreciation and amortization nearly doubled to $90.9M and the prior-year period included a $14.6M gain on re-measurement of a previously held equity interest. The company issued 45.5M common shares during the nine months, raising $2.3B, and completed $1.93B of real estate acquisitions.
- Revenue rose 29.5% YoY to $742.1M in Q3 FY2026.
- Net income fell to $31.2M ($0.14/share) from $55.9M ($0.33/share) a year earlier.
- Depreciation and amortization nearly doubled to $90.9M from $49.2M.
- The company issued 45.5M shares in nine months, raising $2.3B.
- Real estate acquisitions totaled $1.93B in the nine-month period.
Markets closed — no regular-session reaction yet; extended-hours move not captured here.
Strong top-line growth is being offset by heavy acquisition-related dilution and depreciation, cutting EPS by more than half year over year.
The healthcare REIT is scaling aggressively through acquisitions, with total assets up to $7.6B from $5.4B at year-end 2025.
Rapid acquisition-driven growth is diluting per-share results, with weighted-average shares up to 216.8M from 169.0M and EPS down 58% YoY despite revenue growth.